Agonist anti-4-1BB plus neutralizing anti-CTLA-4 or -PD-L1 synergize to promote tumor regression by rescuing dying dysfunctional CD8+ T cells within the tumor microenvironment

Overview of attention for article published in Journal for Immunotherapy of Cancer, November 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)

Mentioned by

patent: 1 patent

Readers on

mendeley: 5 Mendeley

Summary Patents

So far, Altmetric has seen 1 patent that references this research output.

MULTISPECIFIC BINDING AGENTS AGAINST PD-L1 AND CD137 IN COMBINATION

Application WO-2023057534-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.